Portfolio (Quarterly)
Guide ↗
Trails Edge Capital Partners, LP
· CIK 0002077247| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 1,523,022.0 | $49.4M | 7.85% | +204K | +15.4% | $32.45 | +46.7% |
| 2 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 1,573,220.0 | $38.2M | 6.06% | -170K | -9.8% | $24.26 | +10.1% |
| 3 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 1,063,234.0 | $33.8M | 5.36% | +381K | +55.8% | $31.75 | +16.2% |
| 4 | — | FIRST TRACKS BIOTHERAPEUTICS | — | 1,514,000.0 | $30.5M | 4.84% | NEW | — | $20.12 | — |
| 5 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 2,227,917.0 | $29.6M | 4.70% | +925K | +71.0% | $13.30 | +19.0% |
| 6 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 512,000.0 | $29.3M | 4.65% | NEW | — | $57.22 | +16.6% |
| 7 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 2,001,282.0 | $29.0M | 4.60% | +1.1M | +134.9% | $14.47 | +3.6% |
| 8 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 440,000.0 | $26.6M | 4.22% | — | — | $60.36 | +0.7% |
| 9 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 223,312.0 | $26.1M | 4.15% | -110K | -33.0% | $117.07 | -17.7% |
| 10 | INSM | INSMED INC | Healthcare | 230,331.0 | $24.6M | 3.90% | NEW | — | $106.62 | +18.0% |
| 11 | CYTK | CYTOKINETICS INC | Healthcare | 288,089.0 | $24.5M | 3.90% | -12K | -4.0% | $85.19 | -9.8% |
| 12 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 1,110,000.0 | $24.3M | 3.85% | +408K | +58.2% | $21.86 | -10.1% |
| 13 | NGNE | NEUROGENE INC | Healthcare | 714,885.0 | $22.5M | 3.57% | -68K | -8.7% | $31.45 | +22.8% |
| 14 | KLRA | KAILERA THERAPEUTICS INC | Healthcare | 984,786.0 | $21.7M | 3.44% | NEW | — | $22.03 | -22.1% |
| 15 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 115,750.0 | $21.7M | 3.44% | -129K | -52.8% | $187.28 | +11.8% |
| 16 | — | INHIBIKASE THERAPEUTICS INC | — | 9,051,318.0 | $18.4M | 2.92% | +994K | +12.3% | $2.03 | — |
| 17 | INCY | INCYTE CORP | Healthcare | 155,000.0 | $17.6M | 2.79% | NEW | — | $113.36 | +12.7% |
| 18 | — | AVALO THERAPEUTICS INC | — | 891,881.0 | $16.5M | 2.62% | NEW | — | $18.48 | — |
| 19 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 750,000.0 | $14.6M | 2.32% | NEW | — | $19.47 | -19.1% |
| 20 | SNSE | FAETH THERAPEUTICS INC | Healthcare | 515,335.0 | $12.9M | 2.04% | +390K | +312.3% | $25.00 | -44.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%